Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056013 · ClinicalTrials.gov registry record · NA
Vicryl Rapide Versus Nonabsorbable Suture
A NA study of Traumatic Lacerations, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 2
- Study locations
NCT04056013 is a NA study of Traumatic Lacerations that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 96 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT04056013, a NA study of Traumatic Lacerations, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 2
- Study locations
Study Summary
This will be a prospective, randomized controlled trial assessing noninferiority of Vicryl Rapide compared to nonabsorbable suture. The study will be conducted in the Community Regional Medical Center emergency department (ED). The aim of this study, then, is to prospectively determine if 3-month cosmesis for traumatic laceration repair of trunk/extremity lacerations in adult patients with Vicryl Rapide is noninferior to nonabsorbable suture.
Conditions Studied
Interventions
- DEVICE Vicryl Rapide absorbable suture
Study Locations (2)
California
- Community Regional Medical Center - Fresno
- Community Regional Trauma and Burn Center - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2029-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04056013
The ClinicalTrials.gov registry entry for NCT04056013 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Lacerations appearing as the primary indexed condition, and to 1 intervention - of which Vicryl Rapide absorbable suture is the first listed.
NCT04056013 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04056013 about?
NCT04056013 is a clinical study titled "Vicryl Rapide Versus Nonabsorbable Suture". This will be a prospective, randomized controlled trial assessing noninferiority of Vicryl Rapide compared to nonabsorbable suture. The study will be conducted in the Community Regional Medical Center emergency department (ED). The aim of this study, then, is to prospectively determine if 3-month co...
What is the current status of trial NCT04056013?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2019-09-26. Estimated completion is 2029-01-31.
What conditions does trial NCT04056013 study?
This clinical trial studies the following conditions: Traumatic Lacerations.
What interventions are being tested in trial NCT04056013?
The interventions under investigation include: Vicryl Rapide absorbable suture (DEVICE).
Who is sponsoring clinical trial NCT04056013?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04056013 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.